671 – 680 of 2758
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Intravenous immunoglobulin treatment of spleen cells from patients with immune thrombocytopenia significantly increases the percentage of myeloid-derived suppressor cells
(
- Contribution to journal › Letter
-
Mark
The applicability of the translated Edmonton Symptom Assessment System : revised [ESAS-r] in Swedish palliative care
(
- Contribution to journal › Letter
-
Mark
Sialylation of IgG antibodies inhibits IgG-mediated allergic reactions
(
- Contribution to journal › Letter
-
Mark
A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition : The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human Use Does not Change Evidence-based Guideline Recommendations
(
- Contribution to journal › Letter
-
Mark
Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma
(
- Contribution to journal › Letter
-
Mark
The Use of Serum MMP-9 and TIMP-1 in Acute Coronary Syndrome
(
- Contribution to journal › Letter
-
Mark
Decreased post-synaptic density-95 protein expression on dendrites of newborn neurons following CX3CR1 modulation in the epileptogenic adult rodent brain
(
- Contribution to journal › Letter
-
Mark
Temporal development of the gut microbiome in early childhood from the TEDDY study
(
- Contribution to journal › Letter
-
Mark
The human gut microbiome in early-onset type 1 diabetes from the TEDDY study
(
- Contribution to journal › Letter
-
Mark
Ensuring caregivers are part of palliative care service delivery
(
- Contribution to journal › Letter